Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

NCT00701831 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin glargine

Sponsor

Sanofi